register

Digital & Innovation

Human-Artificial intelligence collaboration improves skin cancer diagnosis

Health Industry Hub | June 24, 2020 |

Artificial intelligence (AI) improved skin cancer diagnostic accuracy when used in collaboration with human clinical checks, an international study including University of Queensland researchers has found.

The global team tested for the first time whether a ‘real world’, collaborative approach involving clinicians assisted by AI improved the accuracy of skin cancer clinical decision making.

UQ’s Professor Monika Janda said the highest diagnostic accuracy was achieved when crowd wisdom and AI predictions were combined, suggesting human-AI and crowd-AI collaborations were preferable to individual experts or AI alone

“This is important because AI decision support has slowly started to infiltrate healthcare settings, and yet few studies have tested its performance in real world settings or how clinicians interact with it,” Professor Janda said.

“Inexperienced evaluators gained the highest benefit from AI decision support and expert evaluators confident in skin cancer diagnosis achieved modest or no benefit.

“These findings indicated a combined AI-human approach to skin cancer diagnosis may be the most relevant for clinicians in the future.”

Although AI diagnostic software has demonstrated expert level accuracy in several image-based medical studies, researchers have remained unclear on whether its use improved clinical practice.

“Our study found that good quality AI support was useful to clinicians but needed to be simple, concrete, and in accordance with a given task,” Professor Janda said.

“For clinicians of the future this means that AI-based screening and diagnosis might soon be available to support them on a daily basis.

“Implementation of any AI software needs extensive testing to understand the impact it has on clinical decision making.”

Researchers trained and tested an artificial convolutional neural network to analyse pigmented skin lesions, and compared the findings with human evaluations on three types of AI-based decision support.


News & Trends - MedTech & Diagnostics

Government's claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Government’s claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Health Industry Hub | February 7, 2025 |

The government has unveiled Cancer Australia’s National Framework for Genomics in Cancer Control, a strategic plan designed to guide healthcare […]

More


News & Trends - Pharmaceuticals

Healthcare sector’s political donations: What to expect ahead of the federal election

Healthcare sector’s political donations: What to expect ahead of the federal election

Health Industry Hub | February 7, 2025 |

Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]

More


News & Trends - Pharmaceuticals

'Underinvestment in gynae cancer has left critical gaps,' says ANZGOG Chair

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair

Health Industry Hub | February 7, 2025 |

Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]

More


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


This content is copyright protected. Please subscribe to gain access.